Smoking in pregnancy and subsequent child development

British Medical Journal
|December 8, 1973
PubMed

Insights

Maternal smoking during pregnancy is linked to developmental deficits in children. Increased cigarette consumption after the fourth month of pregnancy correlates with greater physical and cognitive impairments in offspring.

Area of Science:

  • Pediatric Health
  • Developmental Psychology
  • Public Health

Background:

  • Maternal smoking during pregnancy is a significant public health concern.
  • The impact of prenatal smoke exposure on child development requires further longitudinal investigation.

Purpose of the Study:

  • To assess the long-term physical and cognitive effects of maternal smoking during pregnancy on children.
  • To determine if the quantity of cigarettes smoked influences the severity of developmental deficits.

Main Methods:

  • Longitudinal study following a national sample of several thousand children from birth.
  • Assessment of physical growth and cognitive abilities (reading, mathematics, general ability) at ages 7 and 11 years.
  • Statistical analysis accounting for associated social and biological factors.

Main Results:

  • Prenatal exposure to maternal smoking is associated with physical and mental retardation in children at ages 7 and 11.
  • A dose-response relationship was observed: higher maternal cigarette consumption after the fourth month of pregnancy led to greater deficits.
  • Children of mothers smoking 10+ cigarettes daily were, on average, 1.0 cm shorter and 3-5 months behind in cognitive skills compared to non-smokers' offspring.

Conclusions:

  • Maternal smoking during pregnancy has detrimental, measurable effects on child development.
  • The findings highlight the critical importance of smoking cessation during pregnancy for optimal child outcomes.
  • Public health initiatives should focus on reducing smoking rates among pregnant women.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...